Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Bill to regulate healthcare private equity lands on desk of Mass. governor
Gov. Maura Healey has until Jan. 9 to pass the act into law or use her veto powers. The bill passed the state Senate on Dec. 30.
The biggest challenges facing radiology business managers in 2025
RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year.
5 healthcare AI predictions for 2025 from Wolters Kluwer Health
Watch for healthcare AI to increase its footprint in the patient-safety domain over the coming year.
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
Pharmacist Jason Ausili discusses the expanding role of pharmacies as one-stop-shop patient care centers for every community.
10 signs AI is ‘eating the world (of venture capital)’
Some investment analysts are predicting a more permissive M&A market, deregulation as a catalyst for growth and fiscal policies that stimulate economic activity. And they see AI as a catalyst in the shift.

Medical researchers must understand risks associated with AI

AI is poised to change the healthcare industry forever—but risks remain that researchers must take seriously.

January 17, 2020

Hospital, health system model changes drove M&A in 2019

Changing models across hospitals and health systems helped drive mergers and acquisition activity in 2019, according to a new report from Kaufman Hall.

January 16, 2020

Without individual mandate, the ACA chugs along

The Affordable Care Act has remained strong despite the lack of an individual mandate, which was effectively stripped in the 2018 budget by Republicans.

January 16, 2020

UPMC designates $1B investment in life sciences

The innovation and venture capital arm of University of Pittsburgh Medical Center (UPMC) is planning to invest $1 billion into life sciences to develop new drugs, diagnostics and devices over the next four years.

January 15, 2020

More healthcare M&A on the horizon in 2020

Executives in the healthcare space are expecting more M&A activity in 2020 compared to 2019, according to a new outlook from KPMG.

January 14, 2020

How drugmakers are working to get paid for their most expensive treatments

New medical treatments such as gene therapies come with a high price tag up to six figures, and drugmakers are working hard to ensure they can get reimbursed for these medicines in creative ways.

January 14, 2020

Digital health funding slowed in 2019

Global venture capital funding in digital health dropped 6% in 2019, with 615 deals nabbing $8.9 billion in capital.

January 13, 2020

Teladoc acquires InTouch for $600M

Virtual care provider Teledoc Health will acquire InTouch Health for the purchase price of $600M.

January 13, 2020

Around the web

Radiology Business

The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year.

Radiology Business

Policies and regulations shaping radiology in 2025

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.

Cardiovascular Business

FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.